rs2165436

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001111067.4(ACVR1):​c.-183+5412T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.682 in 152,096 control chromosomes in the GnomAD database, including 39,666 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 39666 hom., cov: 32)

Consequence

ACVR1
NM_001111067.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.732

Publications

2 publications found
Variant links:
Genes affected
ACVR1 (HGNC:171): (activin A receptor type 1) Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]
ACVR1 Gene-Disease associations (from GenCC):
  • fibrodysplasia ossificans progressiva
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen, Orphanet
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.845 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACVR1NM_001111067.4 linkc.-183+5412T>C intron_variant Intron 1 of 10 ENST00000434821.7 NP_001104537.1 Q04771D3DPA4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACVR1ENST00000434821.7 linkc.-183+5412T>C intron_variant Intron 1 of 10 1 NM_001111067.4 ENSP00000405004.1 Q04771

Frequencies

GnomAD3 genomes
AF:
0.682
AC:
103693
AN:
151978
Hom.:
39673
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.309
Gnomad AMI
AF:
0.802
Gnomad AMR
AF:
0.810
Gnomad ASJ
AF:
0.774
Gnomad EAS
AF:
0.613
Gnomad SAS
AF:
0.709
Gnomad FIN
AF:
0.849
Gnomad MID
AF:
0.794
Gnomad NFE
AF:
0.850
Gnomad OTH
AF:
0.718
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.682
AC:
103692
AN:
152096
Hom.:
39666
Cov.:
32
AF XY:
0.683
AC XY:
50797
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.308
AC:
12765
AN:
41462
American (AMR)
AF:
0.810
AC:
12388
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.774
AC:
2684
AN:
3468
East Asian (EAS)
AF:
0.613
AC:
3170
AN:
5172
South Asian (SAS)
AF:
0.709
AC:
3416
AN:
4816
European-Finnish (FIN)
AF:
0.849
AC:
8977
AN:
10576
Middle Eastern (MID)
AF:
0.786
AC:
231
AN:
294
European-Non Finnish (NFE)
AF:
0.850
AC:
57825
AN:
67996
Other (OTH)
AF:
0.713
AC:
1506
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1254
2509
3763
5018
6272
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.733
Hom.:
5757
Bravo
AF:
0.661
Asia WGS
AF:
0.623
AC:
2169
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
7.1
DANN
Benign
0.59
PhyloP100
0.73
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2165436; hg19: chr2-158726896; API